38-Year-Old Male Presents With Lower Extremity Edema


Article Author:
Matthew Cossack
Mark Castera


Article Editor:
Khalid Bashir


Editors In Chief:
Venkat Minnaganti
John Brusch
Janak Koirala


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Frank Smeeks
Kristina Soman-Faulkner
Radia Jamil
Patrick Le
Sobhan Daneshfar
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Navid Mahabadi
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
2/18/2019 9:14:23 PM

Case Presentation

A 38-year-old African American male, who emigrated from Somalia 10 years ago, presented with a 6-month history of lower extremity swelling, 20-pound weight gain over 4 weeks and new onset microscopic hematuria. He had no prior history of edema, proteinuria or hematuria. There was no prior history of any systemic illness or any heart, lung or kidney disease. He reported no over-the-counter drug use, herbal medication use or NSAID intake. His review of systems was positive for lethargy, fatigue, and edema at his lower extremities. His family history was negative for any kidney disease. He reported a monogamous relationship with his wife and no current or past alcohol or drug use. His medical history included recently diagnosed hypertension, latent tuberculosis, and anemia. His vital signs included a blood pressure of 160/90 and a heart rate of 78.

His physical exam revealed clear lungs and a normal heart exam on auscultation. His abdomen was soft and non-tender, and his skin was warm and dry with no rash. He had 2 plus pitting edema at the ankles. Initial laboratory data was consistent with acute kidney injury (AKI) with worsening creatinine from 1.2 to 1.6 over 1 month and nephrotic range proteinuria. Serologies for hepatitis B, hepatitis C, anti-nuclear antibody (ANA), c-ANCA, serine protease 3 (PR3) IgG, myeloperoxidase antibody (MPO), and complement levels were sent. He was started on losartan for proteinuria with plans for renal biopsy; however, he was lost to follow up. The patient then presented two weeks later with worsening edema to his waist, continued weight gain, mild hemoptysis, and streaks of blood in the stool. Physical examination now showed worsening pitting edema up to his waist with new non-pruritic, erythematous excoriations on the medial aspect of his thighs bilaterally. He was admitted to the hospital with concern for a worsening vasculitis. He was started on oral prednisone and underwent renal biopsy. For his edema, he was started on diuretics to which he responded well. Due to persistent leukopenia, thrombocytopenia, and anemia, human immunodeficiency virus (HIV) testing was performed to complete the workup.

Initial Evaluation

His initial serological testing sent at the time of his first visit was negative except for low C3 levels and a positive c-ANCA and PR3 IgG, a marker for granulomatosis with polyangiitis (GPA), formerly known as Wegener granulomatosis.[1]  Laboratory studies at the time of admission revealed a white-cell count of 4100 /mm, platelets 119,000/dL, hemoglobin 9.9 g/dL, worsening serum creatinine at 2.3, and total urine protein 6.95 every 24 hours.

Differential Diagnosis

The differential diagnosis for acute kidney injury associated with nephrotic range proteinuria and a low C3 level and a positive cANCA was confusing as ANCA related vasculitis is not associated with low complements and his infectious and autoimmune workup typically causing low complements was negative.

His differential diagnosis included:

Vasculitis

Vasculitis including granulomatosis with polyangiitis, polyarteritis nodosa, Churg-Strauss Syndrome, IgA vasculitis, cryoglobulinemia, immune complex-associated vasculitis (infectious, SLE, or drug hypersensitivity), giant cell arteritis, leukocytoclastic vasculitis.

Glomerular Disease

Primary Glomerular Disease due to:

  • Focal segmental glomerulosclerosis
  • Membranous nephropathy
  • Other proliferative glomerulonephritides (focal, “pure mesangial,” IgA nephropathy)
  • Membranoproliferative glomerulonephritis and dense deposit disease
  • Minimal change disease

Secondary Glomerular Disease due to:

  • Systemic lupus erythematosus (SLE)
  • Drugs (NSAIDs, penicillamine, heroin)
  • Infection (schistosomiasis, malaria, syphilis, hepatitis B & C, HIV)
  • Malignant disease (carcinoma, lymphoma)
  • Diabetes mellitus
  • Hereditary nephritis.

Confirmatory Evaluation

HIV ELISA and confirmatory western blot were positive for HIV-1.[2] His CD4 count was 16 cells/mm and HIV RNA level was over 378,000 copies/mL. Syphilis and schistosoma serology were negative. Renal biopsy showed an immune complex-associated proliferative glomerulonephritis with membranoproliferative features (Figures 1a-1d).  In this patient with HIV, these pathologic findings were highly suggestive of HIV-associated immune complex kidney disease (HIVICK), a lupus-like nephritis variant. Evidence of collapsing focal segmental glomerulosclerosis (HIV-associated nephropathy) was not identified.

Diagnosis

Based on pathologic findings a diagnosis of HIV-associated immune complex kidney disease (HIVICK) was established.

Management

He was discharged on trimethoprim/sulfamethoxazole and azithromycin prophylaxis and started on antiretroviral therapy (ART) once his HIV genotype was determined. Throughout the hospitalization, diuresis was continued with furosemide, and his renal function improved with his creatinine down to 1.7 before starting abacavir-dolutegravir-lamivud.

Discussion

Once infected with HIV-1, the development of AIDS can be delayed up to 10 to 20 years.[3] Many individuals who seroconvert to HIV have generalized symptoms of fatigue, fever, rash, lymphadenopathy, weight loss, and myalgias.[4][5] This is an unusual presentation of HIV immune complex kidney disease (HIVICK) with newly diagnosed AIDS. This case is also atypical due to c-ANCA positivity in the presence of HIV disease.

It is important to know the limitations of laboratory data when approaching a patient with newly diagnosed renal failure. Positivity of ANCA has been found secondary to HIV infection in up to 20% to 83% of cases, with a proposed mechanism being polyclonal activation of B cells. The sensitivity of c-ANCA for GPA is 64% with indirect immunofluorescence.[6]

Renal disease in the setting of HIV manifests in several ways. HIV-associated nephropathy (HIVAN) is a form of focal segmental glomerulosclerosis with interstitial inflammation and microcysts involving direct infiltration of renal tubular and glomerular cells by HIV.[7] HIVAN is more common in advanced HIV and the black race and is associated with significant proteinuria and a rapid decline in renal function. Among the different risk factors for developing end-stage renal disease (ESRD) in HIV-infected individuals, black race is the most important factor due to the ApoL1 gene mutation. In the United States from 2002 to 2006, 88% of HIV patients with ESRD were black.[8][9]  These patients almost always have HIVAN. HIVAN is rarely associated with patients already on ART with normal CD4 counts. These individuals benefit from ART and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, but glucocorticoids have not been found to be helpful. The prognosis is poor and patients often reach ESRD with hemodialysis dependence. Despite ART, RNA viral expression can persist with the kidneys as an important reservoir for HIV-1.[10]

Another form of renal disease in the setting of HIV is called HIV immune complex kidney disease (HIVICK). It is also usually seen in advanced HIV and black race. The prognosis is also poor with 32% of patients reaching ESRD status within two years.[11] Unlike HIVAN, the beneficial role of ART has not been shown. Other forms of renal disease in the setting of HIV include IgA nephropathy, membranoproliferative glomerulonephritis, renal tubular acidosis, amyloid, acute postinfectious glomerulonephritis, membranous nephropathy, focal and segmental necrotizing glomerulonephritis, immunotactoid nephropathy, and thrombotic microangiopathy.[12]

Before starting ART in an antiretroviral naïve patient with impaired renal function, there are several considerations to keep in mind.  First, certain ART medications require renal adjustment or are contraindicated with impaired renal function.[13] Second, after ART is initiated, follow up to monitor renal function for new onset or worsening renal disease is crucial as this can modify therapy. Third, screening for the HLA-B*5701 allele must be addressed before starting ART as HLA-B*5701 positivity predisposes the patient to a hypersensitivity reaction (abacavir) that can be life-threatening.[14] This can pose a challenging dilemma for cost, compliance, and efficacy as abacavir is included in many of the current one-pill ART regimens.

Having HIV is no longer a contraindication for renal transplantation. The Infectious Diseases Society of America (IDSA) strongly recommends the evaluation of HIV patients with ESRD or imminent ESRD for kidney transplantation after considering comorbidities, history of opportunistic infections, and virologic response with ART.[13]

Pearls of Wisdom

The initial approach to a patient with new-onset lower extremity edema can be challenging, with the initial workup, often focusing on the hepatic, cardiovascular or renal system.  Screening for a vasculitic process is often performed, particularly when it involves the renal or pulmonary systems. It is important to understand the significance and limitations of serological markers when evaluating the patient.  This case aims to highlight the potential pitfalls of positive serologic markers and the importance of keeping a broad differential in new-onset lower extremity swelling. 

This review separating vasculitic renal disease from infectious etiology highlights the importance of not empirically treating a patient with positive serological markers for vasculitis with cytotoxic agents as this could be disastrous for a patient with HIV. This case also presents an atypical presentation of HIV infection and the need to have a high index of suspicion for the disease, even when risk factors are not apparent. Treatment regimens will also differ for an HIV patient with concomitant renal impairment and special considerations must be given before starting ART.

Enhancing Healthcare Team Outcomes

This case presents an excellent opportunity to discuss the importance of an interprofessional team management of managing patients with renal failure and HIV. Having either HIV or renal failure can overwhelm patients due to the complexity of care required for proper management and the need for long-term treatment. Patients with renal failure who depend on hemodialysis experience extraordinarily high burdens of stress which adversely affect treatment compliance and subsequent outcomes. Thankfully, interprofessional management of dialysis patients delivers a multitude of benefits including better clinical outcomes, cost savings, and improved patient quality of life.[15] An HIV diagnosis carries significant stigma which negatively affects treatment outcomes and quality of life metrics. HIV care teams composed of physicians, pharmacists, nurses, counselors, psychologists, and social workers provide necessary holistic support to patients with demonstrable clinical improvements.[16] Complex HIV medication regimens are best managed by multidisciplinary involvement of pharmacists to help anticipate and avoid drug-drug interactions which can cause significant side effects or reduce the efficacy of treatment.[17]


  • Image 6848 Not availableImage 6848 Not available
    Contributed by Agnes Colanta, MD
Attributed To: Contributed by Agnes Colanta, MD

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

38-Year-Old Male Presents With Lower Extremity Edema - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following serologic markers is typically associated with granulomatosis with polyangiitis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
HIV immune complex kidney disease (HIVICK) is commonly found in which of the following ethnicities?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which gene mutation is an important factor leading to the development of end-stage renal disease from an HIV infection?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 34-year-old patient presents with a history of risky exposures including intravenous drug use and unprotected sexual intercourse with multiple partners. Out of concern for potential HIV exposure, a screening test (HIV-1/2 antigen/antibody combination immunoassay) is ordered which is positive. What is the next step in management?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient recently diagnosed with HIV started combination antiretroviral therapy including abacavir one week ago and has since developed fevers, a rash, and gastrointestinal upset. Which of these alleles could be responsible for this reaction?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

38-Year-Old Male Presents With Lower Extremity Edema - References

References

Rasmussen N,Wiik A,Jayne DR, A historical essay on detection of anti-neutrophil cytoplasmic antibodies. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2015 Apr     [PubMed]
Wesolowski LG,Wroblewski K,Bennett SB,Parker MM,Hagan C,Ethridge SF,Rhodes J,Sullivan TJ,Ignacio-Hernando I,Werner BG,Owen SM, Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithm. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2015 Apr     [PubMed]
Muñoz A,Kirby AJ,He YD,Margolick JB,Visscher BR,Rinaldo CR,Kaslow RA,Phair JP, Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1995 Apr 15     [PubMed]
Kahn JO,Walker BD, Acute human immunodeficiency virus type 1 infection. The New England journal of medicine. 1998 Jul 2     [PubMed]
Tindall B,Barker S,Donovan B,Barnes T,Roberts J,Kronenberg C,Gold J,Penny R,Cooper D, Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Archives of internal medicine. 1988 Apr     [PubMed]
Jansen TL,van Houte D,de Vries T,Wolthuis A, ANCA seropositivity in HIV: a serological pitfall. The Netherlands journal of medicine. 2005 Jul-Aug     [PubMed]
Ross MJ,Bruggeman LA,Wilson PD,Klotman PE, Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy. Journal of the American Society of Nephrology : JASN. 2001 Dec     [PubMed]
Winston JA, HIV and CKD epidemiology. Advances in chronic kidney disease. 2010 Jan     [PubMed]
Genovese G,Friedman DJ,Ross MD,Lecordier L,Uzureau P,Freedman BI,Bowden DW,Langefeld CD,Oleksyk TK,Uscinski Knob AL,Bernhardy AJ,Hicks PJ,Nelson GW,Vanhollebeke B,Winkler CA,Kopp JB,Pays E,Pollak MR, Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (New York, N.Y.). 2010 Aug 13     [PubMed]
Winston JA,Bruggeman LA,Ross MD,Jacobson J,Ross L,D'Agati VD,Klotman PE,Klotman ME, Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. The New England journal of medicine. 2001 Jun 28     [PubMed]
Foy MC,Estrella MM,Lucas GM,Tahir F,Fine DM,Moore RD,Atta MG, Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. Clinical journal of the American Society of Nephrology : CJASN. 2013 Sep     [PubMed]
D'Agati V,Appel GB, Renal pathology of human immunodeficiency virus infection. Seminars in nephrology. 1998 Jul     [PubMed]
Lucas GM,Ross MJ,Stock PG,Shlipak MG,Wyatt CM,Gupta SK,Atta MG,Wools-Kaloustian KK,Pham PA,Bruggeman LA,Lennox JL,Ray PE,Kalayjian RC, Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014 Nov 1     [PubMed]
Mallal S,Phillips E,Carosi G,Molina JM,Workman C,Tomazic J,Jägel-Guedes E,Rugina S,Kozyrev O,Cid JF,Hay P,Nolan D,Hughes S,Hughes A,Ryan S,Fitch N,Thorborn D,Benbow A, HLA-B*5701 screening for hypersensitivity to abacavir. The New England journal of medicine. 2008 Feb 7     [PubMed]
Hashemi MS,Irajpour A,Abazari P, Improving Quality of Care in Hemodialysis: a Content Analysis. Journal of caring sciences. 2018 Sep     [PubMed]
Elgalib A,Al-Sawafi H,Kamble B,Al-Harthy S,Al-Sariri Q, Multidisciplinary care model for HIV improves treatment outcome: a single-centre experience from the Middle East. AIDS care. 2018 Sep     [PubMed]
Molas E,Luque S,Retamero A,Echeverría-Esnal D,Guelar A,Montero M,Guerri R,Sorli L,Lerma E,Villar J,Knobel H, Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team. HIV clinical trials. 2018 Feb     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Infectious Disease. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Infectious Disease, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Infectious Disease, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Infectious Disease. When it is time for the Infectious Disease board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Infectious Disease.